Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer
Sònia Palomeras(Universitat de Girona), Teresa Puig(Universitat de Girona)
Cited by 72
Related Papers
Different fatty acid metabolism effects of (−)-Epigallocatechin-3-Gallate and C75 in Adenocarcinoma lung cancer
|BMC Cancer|2012|101
Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs
|PLoS ONE|2015|67
(−)-Epigallocatechin 3-Gallate Synthetic Analogues Inhibit Fatty Acid Synthase and Show Anticancer Activity in Triple Negative Breast Cancer
|Molecules|2018|45